Skip to main content
Livermore
Livermore
ZHEN

Millennium Management LLC

SEC CIK
0001273087
Latest filing
Aug 14, 2026

FDMT holding history

4D Molecular Therapeutics, Inc. in every 13F filed by Millennium Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FDMT overviewAll 13F holders of FDMTFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of FDMT by Millennium Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−96,364−100.0%Sold outHolders
Q4 202596,364$722.7K<0.1%−1,053,037−91.6%ReducedHolders
Q3 20251,149,401$9.99M<0.1%−334,323−22.5%ReducedHolders
Q2 20251,483,724$5.50M<0.1%−150,263−9.2%ReducedHolders
Q1 20251,633,987$5.28M<0.1%+213,264+15.0%AddedHolders
Q4 20241,420,723$7.91M<0.1%+1,337,497+1,607.1%AddedHolders
Q3 202483,226$899.7K<0.1%+49,382+145.9%AddedHolders
Q2 202433,844$710.4K<0.1%+22,400+195.7%AddedHolders
Q1 202411,444$364.6K<0.1%+11,444NewHolders
Q4 20230$00.0%−331,516−100.0%Sold outHolders
Q3 2023331,516$4.22M<0.1%+52,815+19.0%AddedHolders
Q2 2023278,701$5.04M<0.1%+278,701NewHolders
Q1 20230$00.0%−287,483−100.0%Sold outHolders
Q4 2022287,483$6.38M<0.1%+27,374+10.5%AddedHolders
Q3 2022260,109$2.09M<0.1%−14,319−5.2%ReducedHolders
Q2 2022274,428$1.92M<0.1%+197,504+256.8%AddedHolders
Q1 202276,924$1.16M<0.1%+76,924NewHolders
Q4 20210$00.0%−155,258−100.0%Sold outHolders
Q3 2021155,258$4.19M<0.1%−196,793−55.9%ReducedHolders
Q2 2021352,051$8.48M<0.1%+17,902+5.4%AddedHolders
Q1 2021334,149$14.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.